BUZZ-U.S. STOCKS ON THE MOVE-Tracon, OHR Pharma, Graftech, Doral
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)
The Nasdaq Composite index hit the 5,000 mark on Monday for the first time since March 27, 2000 and edged closer to its 5,132.52 all-time peak it reached that same month in the frenzy of the dot-come bubble. The Dow Jones industrial average was up 0.59 percent at 18,240.33, the S&P 500 was up 0.33 percent at 2,111.37 and the Nasdaq Composite was up 0.47 percent at 4,986.878.
** TRACON PHARMACEUTICALS INC, $19.28, +43.56 pct
Stifel Nicolaus raised price target on the drug developer's stock to $20 from $16. Company said on Friday that its experimental cancer drug was effective in improving overall survival in patients with advanced renal cell carcinoma, a type of kidney cancer, in an early-stage study.
** OHR PHARMACEUTICAL INC, $10.4, +35.24 pct
The eye drug developer said the mid-stage study of its squalamine eye drops improved vision by week 4 in patients with a wet form of age-related blindness, when used in combination with lucentis. Cowen and Co initiated coverage of the stock with an "outperform" rating and price target of $25.
** GRAFTECH INTERNATIONAL LTD, $4.63, +18.72 pct Continued...